Hepatology

Autoimmune Liver Disease

Questions discussed in this category

How will the recent withdrawal of Ocaliva for the treatment of PBC impact your therapeutic and management plan for these patients?

1 Answer available

What is your strategy in the management of patients with autoimmune hepatitis who failed azathioprine therapy and what parameters do you monitor with what frequency?

1 Answer available

What patient factors guide your selection of maintenance therapies for a patient with autoimmune hepatitis?

1 Answer available

What is your approach to induction therapy and maintenance therapy for patients with autoimmune hepatitis?

1 Answer available

How do you manage liver enzyme elevations in patients with PBC after starting elanifibranor?

1 Answer available

What is your approach to the management of anti-pruritic therapies in patients with cholestatic liver disease?

Any management considerations with respect to disease etiology?

1 Answer available

How do you approach restarting immunotherapy in a patient with metastatic melanoma who previously developed immune-mediated hepatitis (Grade 3), with liver enzymes now back to baseline levels?

Given the improvement in liver function, what factors should be considered before reinitiating immunotherapy?"

4 Answers available

Papers discussed in this category

Cancer chemotherapy and pharmacology, 2019 Aug 23

Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer.

Related Topics in Hepatology